Obama All but Calls Cosby a Serial Rapist
Shock of the Day

Obama All but Calls Cosby a Serial Rapist

A worker cleans graffiti on actor Bill Cosby's star on the Hollywood Walk of Fame in Los Angeles December 5, 2014. REUTERS/Phil McCarten
PHIL McCARTEN
By Eric Pianin

For months, comedian Bill Cosby has come under relentless attack amid allegations that he raped dozens of women over the years after slipping them drugs. As the controversy grew, some on Capitol Hill questioned whether something should be done to strip the long-celebrated actor of a Presidential Medal of Freedom awarded him in 2002 during the Bush administration.

Today at a White House news conference, President Obama abruptly veered from an extensive defense of the Iran nuclear deal to a thinly veiled denunciation of Cosby as a serial rapist. In response to a reporter’s question of whether he would consider rescinding the medal, Obama said, “There’s no precedent for revoking a medal,” and that “we don’t have the mechanism.”

Then, after  noting that he rarely publicly discusses pending civil law suits that  might result in criminal charges, he made this startling pronouncement: “I’ll say this: If you give a woman -- or a man for that matter -- without his or her knowledge a drug and then have sex with that person without consent, that’s rape.”

It was a dramatic moment as the first African American president in U.S. history denounced from the White House pulpit the conduct of one of the most prominent and (once) beloved black actors and comedians of modern times.

Related: Bill Cosby's Moralizing Comes Back to Haunt Him

Cosby and his lawyers for months have dismissed as fantasy claims by more than two dozen women that they had been sexually assaulted by the actor over the past several decades – frequently after having been given knock-out drugs to make them groggy or put them to sleep.

But this ‘he said-she said’  controversy came to an end earlier this month after Cosby had admitted in a deposition giving Quaaludes to women he wanted to have sex with.

The documents, dating back to 2005, stem from a civil lawsuit filed by Andrea Constand -- one of the dozens of women who have publicly accused the comedian of sexual assault. The records were made public after The Associated Press went to court to compel their release.

Following that report, Sens. Kirsten Gillibrand (D-NY) and Claire McCaskill (D-MO) said it was an outrage that Cosby continued to hold the highest civilian honor in America. In a statement to Politico, a spokeswoman for Gillibrand said Cosby's medal must be revoked "because we need to set a clear example that sexual assault will not be tolerated in this country."

Obama apparently agrees with the senators, but just doesn’t know what he could do to take the medal back. 

Tax Refunds Rebound

Flickr / Chris Potter
By The Fiscal Times Staff

Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years. 

Number of the Day: $22 Trillion

iStockphoto/The Fiscal Times
By The Fiscal Times Staff

The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.

Chart of the Week: The Soaring Cost of Insulin

Client Sanon has her finger pricked for a blood sugar test in the Family Van in Boston
REUTERS/Brian Snyder
By The Fiscal Times Staff

The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494. 

Chart of the Day: Shutdown Hits Like a Hurricane

An aerial view shows a neighborhood that was flooded after Hurricane Matthew in Lumberton, North Carolina
© CHRIS KEANE / Reuters
By Michael Rainey

The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said. 

Chart of the Week: Lowering Medicare Drug Prices

A growing number of patients are being denied access to newer oral chemotherapy drugs for cancer pills with annual price tags of more than $75,000.
iStockphoto
By Michael Rainey

The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.

In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.